Royal Bank of Canada downgraded Caribou Biosciences stock, and Leerink partners updated its ratings on October 9, 2026.
2 reports, 2 independent
Updated Sat 00:00
No new developments lately
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada downgraded Caribou Biosciences stock, and Leerink partners updated its ratings on October 9, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink partners downgraded Caribou Biosciences stock from outperform to market perform.1 source
RBC downgraded Caribou Biosciences stock and Leerink updated ratings.1 source
Keep exploring
The entities involved
-
Caribou Biosciences
company in Berkeley, United States
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
- Financial institutions made various moves on June 18, 2026, including TD Cowen lowering its price objective, Citigroup raising its target, and Royal Bank of Canada increasing its target price. Separately, Man Group reduced its stock holdings.
- Royal Bank of Canada increased its holdings in the iShares MSCI United Kingdom ETF on June 30, 2026.
-
Leerink partners
U.S. investment bank